Cancer Research Matters – Entrepreneurial deep dive

Simon Boulton
Principal Group Leader, The Francis Crick Institute
Co-founder & VP Science Strategy, Artios Pharma Ltd
Chief Translation Advisor, Cancer Research UK

Simon’s lab has discovered new DNA repair genes and provided novel insights into cancer. Artios are developing new treatments that target DNA repair pathway vulnerabilities to selectively kill cancer cells. Simon is also Chief Translation Advisor at Cancer Research UK, with the remit to guide translation and commercialisation of novel cancer therapeutics.

Tony Hickson
Chief business officer, Cancer Research UK and Cancer Research Horizons

Tony leads the Commercial Partnerships team responsible for the commercialisation of IP from Cancer Research UK-funded projects, new start-up creation, licences and corporate alliances.

Faith Howard
Postdoctoral Research Associate, University of Sheffield
Co-Founder at NANOncolytics

Faith’s research interests are focused on delivery of therapeutics to disseminated tumours. This includes nanoenabled formulations and the development of appropriate models for studying immunotherapies. She is cofounder of NANOncolytics, a company developing nanoparticle technology to provide a less invasive strategy for treating inaccessible and aggressive tumours.

Tommy Rennison
Regional Translation Lead, Cancer Research Horizons

Tommy is responsible for sourcing and evaluating potential new projects for Cancer Research Horizons.

Phil Berry
Translation Executive at Cancer Research Horizons 

Phil is responsible for sourcing and evaluating potential new projects for Cancer Research Horizons.